|Bid||27.40 x 100|
|Ask||33.63 x 100|
|Day's Range||29.70 - 31.24|
|52 Week Range||24.81 - 33.96|
|PE Ratio (TTM)||-121.95|
|Earnings Date||Jul 31, 2017 - Aug 4, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||31.60|
REDWOOD CITY, Calif., May 25, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will present at the Jefferies 2017 Healthcare Conference in New York City on Tuesday, June ...
On May 16, we issued an updated research report on Redwood City, CA-based Genomic Health Inc. (GHDX).
Genomic Health, Inc. (GHDX), a global cancer company, recently presented positive results for its Oncotype DX Genomic Prostate Score (GPS) test.